Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

PEVs effectively deliver minoxidil through skin.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Niosomes are a promising and effective way to deliver drugs through the skin.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Using iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles increases drug release but reduces its targeting to hair follicles.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.

Drugs penetrate scalp skin better than abdominal skin, with scalp hair follicles aiding in higher drug delivery.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced human skin models improve drug development and could replace animal testing.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Optimized film improves finasteride skin absorption and treatment efficiency.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

New drugs for heart disease may be developed from molecules secreted by stem cells.